Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Watkins

Showing results (61-70 of 163) with videos related to

Pageof 17
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2012
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivoBrian Moldt, Eva G Rakasz, Niccole Schultz, et al.
Journal of Virology|April 28, 2006
The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replicationLevi J Yant, Thomas C Friedrich, Randall C Johnson, et al.
Journal of Virology|November 12, 2005
Tat(28-35)SL8-specific CD8+ T lymphocytes are more effective than Gag(181-189)CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assayJohn T Loffredo, Eva G Rakasz, Juan Pablo Giraldo, et al.
Virology|March 11, 2014
Improved genetic stability of recombinant yellow fever 17D virus expressing a lentiviral Gag gene fragmentMarlon G Veloso de Santana, Patrícia C C Neves, Juliana Ribeiro dos Santos, et al.
Journal of Virology|July 5, 2005
CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too littleMatthew R Reynolds, Eva Rakasz, Pamela J Skinner, et al.
Journal of Virology|November 13, 2009
Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-LAnn J Hessell, Eva G Rakasz, David M Tehrani, et al.
Science (New York, N.Y.)|July 26, 2008
HIV vaccine research: the way forwardAnthony S Fauci, Margaret I Johnston, Carl W Dieffenbach, et al.
The Journal of Infectious Diseases|February 3, 2006
Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infectionJacob D Estes, Qingsheng Li, Matthew R Reynolds, et al.
Journal of Virology|December 1, 2006
Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replicationChungwon Chung, Wonhee Lee, John T Loffredo, et al.
Journal of Virology|July 17, 2009
Novel translation products from simian immunodeficiency virus SIVmac239 Env-encoding mRNA contain both Rev and cryptic T-cell epitopesNicholas J Maness, Jonah B Sacha, Shari M Piaskowski, et al.
Pageof 17

Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2012
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivoBrian Moldt, Eva G Rakasz, Niccole Schultz, et al.
Journal of Virology|April 28, 2006
The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replicationLevi J Yant, Thomas C Friedrich, Randall C Johnson, et al.
Journal of Virology|November 12, 2005
Tat(28-35)SL8-specific CD8+ T lymphocytes are more effective than Gag(181-189)CM9-specific CD8+ T lymphocytes at suppressing simian immunodeficiency virus replication in a functional in vitro assayJohn T Loffredo, Eva G Rakasz, Juan Pablo Giraldo, et al.
Virology|March 11, 2014
Improved genetic stability of recombinant yellow fever 17D virus expressing a lentiviral Gag gene fragmentMarlon G Veloso de Santana, Patrícia C C Neves, Juliana Ribeiro dos Santos, et al.
Journal of Virology|July 5, 2005
CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too littleMatthew R Reynolds, Eva Rakasz, Pamela J Skinner, et al.
Journal of Virology|November 13, 2009
Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-LAnn J Hessell, Eva G Rakasz, David M Tehrani, et al.
Science (New York, N.Y.)|July 26, 2008
HIV vaccine research: the way forwardAnthony S Fauci, Margaret I Johnston, Carl W Dieffenbach, et al.
The Journal of Infectious Diseases|February 3, 2006
Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infectionJacob D Estes, Qingsheng Li, Matthew R Reynolds, et al.
Journal of Virology|December 1, 2006
Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replicationChungwon Chung, Wonhee Lee, John T Loffredo, et al.
Journal of Virology|July 17, 2009
Novel translation products from simian immunodeficiency virus SIVmac239 Env-encoding mRNA contain both Rev and cryptic T-cell epitopesNicholas J Maness, Jonah B Sacha, Shari M Piaskowski, et al.
Pageof 17